BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1155530)

  • 1. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin E2 methyl ester.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Dec; 123(7):665-70. PubMed ID: 1200057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2alpha (THAM) suppositories.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Dec; 10(6):1037-45. PubMed ID: 1208882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginally administered 16, 16-dimethyl-PGE2 for the induction of midtrimester abortion.
    Martin JN; Bygdeman M; Ramadan M; Gréen K; Leader A; Lundström V; Wiqvist N
    Prostaglandins; 1976 Jan; 11(1):123-32. PubMed ID: 769088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
    Ballard CA
    Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.